Clinical, guidelines for hyperkinetic disorder. MRC Child Psychiatry Unit, Institute of Psychiatry, London, UK
Taylor E, Sergeant J, Doepfner M, et al. Clinical, guidelines for hyperkinetic disorder. MRC Child Psychiatry Unit, Institute of Psychiatry, London, UK. Eur Child Adolesc Psychiatry 1998;7:184-200.
Efficacy of atomoxetine versus placebo in school age girls with attention-deficit/hyperactivity disorder
Biederman J, Heiligenstein J. Efficacy of atomoxetine versus placebo in school age girls with attention-deficit/hyperactivity disorder. Pediatrics 2002;110:e75.
Diagnosis of Attention Deficit/ Hyperactivity Disorder
US Department of Health and Human Services, Agency for Health Care Policy and Research; Agency for Health Care Policy and Research:. AHCPR publication 99-0050
Green M, Wong M, Atkins D, et al. Diagnosis of Attention Deficit/ Hyperactivity Disorder. Technical Review 3. US Department of Health and Human Services, Agency for Health Care Policy and Research; Agency for Health Care Policy and Research:1999. AHCPR publication 99-0050.
A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children
Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry 2003;42:886-94.
Clonidine treatment of hyperactive and impulsive children with autistic disorder
Jaselskis CA, Cook EH Jr, Fletcher KE, et al. Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol 1992;12:322-7.
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1999;38:1551-7.